Overview

Bioequivalence Study of Amlodipine and Norvasc Under Fasting and FED Conditions in Chinese Healthy Volunteers

Status:
Completed
Trial end date:
2017-03-21
Target enrollment:
Participant gender:
Summary
This study evaluates the pharmacokinetics and bioequivalence of Amlodipine Besylate Tablets 5 mg versus Norvasc 5 mg tablets administered as 5 mg tablet in healthy volunteers with a washout period of 14 days
Phase:
Phase 1
Details
Lead Sponsor:
Shanghai Haini Pharmaceutical Co., Ltd.
Treatments:
Amlodipine